While BRN2-mediated regulation of MITF is not likely to be important for non-melanoma cancers that do not express MITF, the ability of BRN2 to modulate PTEN expression uncovered here may play an equally important role in promoting the initiation and progression of these cancer types. Here, POU3F2 is linked to melanoma.